Holen Sie sich die Stockscreener-App
7.63
4.33%
-0.34
Schlusskurs vom Vortag:
$7.97
Offen:
$7.9
24-Stunden-Volumen:
53,891
Relative Volume:
0.23
Marktkapitalisierung:
$215.07M
Einnahmen:
$61.86M
Nettoeinkommen (Verlust:
$-11.43M
KGV:
-15.84
EPS:
-0.4818
Netto-Cashflow:
$-12.52M
1W Leistung:
-1.87%
1M Leistung:
+18.58%
6M Leistung:
-4.93%
1J Leistung:
+2.35%
1-Tages-Spanne:
$7.51
$7.90
1-Wochen-Bereich:
$7.51
$8.15
52-Wochen-Spanne:
$4.31
$9.555
Journey Medical Corp Stock (DERM) Company Profile
Firmenname
Journey Medical Corp
Sektor
Telefon
480-434-6670
Adresse
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
7.62 | 224.95M | 61.86M | -11.43M | -12.52M | -0.4818 |
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 58.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.73 | 42.84B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.185 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.53 | 30.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
499.66 | 21.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-30 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-06-28 | Fortgesetzt | ROTH MKM | Buy |
| 2021-12-07 | Eingeleitet | B. Riley Securities | Buy |
Journey Medical Corp Aktie (DERM) Neueste Nachrichten
Journey Medical Corporation to Participate in September 2026 Investor Conferences - Yahoo! Finance Canada
Shinon Healthcare Receives Honors at Sanjeevani 2026 for Medical Value Travel Leadership, Advancing the 'Heal in India' Vision - indiagazette.com
Fortress Biotech's business presentation goes online Sept. 11 - Stock Titan
Journey Medical Corp (DERM) Key Financial Ratios – Valuation, Profitability & More - Value Research
Audubon’s Globus Medical Acquires Duke Spinout Higgs Boson Health - BioBuzz
DERM Should I Buy - Intellectia AI
Journey Medical Corp (DERM) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
536,000 Shares in Journey Medical Corporation $DERM Acquired by Punch & Associates Investment Management Inc. - MarketBeat
J. Goldman & Co LP Takes Position in Journey Medical Corporation $DERM - MarketBeat
DERM | Journey Medical Corporation Common FinancialsRevenue Breakdown - Quiver Quantitative
Journey Medical: Q2 Report Confirms Thesis On Track As Emrosi Launch Gains Traction - Seeking Alpha
FY2026 EPS Estimates for Journey Medical Lowered by Analyst - MarketBeat
Teleconferência de Resultados do 2T26 da Journey Medical (FBIO): Receita cresce 23% com aceleração do Emrosi - TradingKey
Q3 EPS Estimates for Journey Medical Cut by HC Wainwright - MarketBeat
Conferencia de resultados del T2 de 2026 de Journey Medical (FBIO): los ingresos aumentan un 23% a medida que Emrosi se acelera - TradingKey
Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates - tradingkey.com
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - The Manila Times
Analyst Reiterates Buy on Journey Medical as Emrosi Outperformance Supports Unchanged $13 Price Target - TipRanks
Journey Medical's (DERM) Buy Rating Reaffirmed at B. Riley Financial - MarketBeat
Why is Journey Medical stock rallying today? - Investing.com
Why is Journey Medical stock rallying today? By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
A. G. P. Maintains Journey Medical(DERM.US) With Buy Rating, Cuts Target Price to $14 - Moomoo
Wasatch Advisors LP Buys 725,560 Shares of Journey Medical Corporation $DERM - MarketBeat
Journey Medical earnings beat by $0.12, revenue topped estimates - Investing.com Canada
Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ... - Yahoo Finance
DERM Looks 49.2% Overvalued on GF Value™ - GuruFocus
Journey Medical Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Journey Medical Q2 Earnings Call Highlights - MarketBeat
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q2 Earnings - Yahoo Finance
Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings call transcript: Journey Medical tops Q2 2026 forecasts as stock rises - Investing.com
Earnings call transcript: Journey Medical posts Q2 2026 revenue gain, turns EBITDA positive - Investing.com
Journey Medical (NASDAQ:DERM) Posts Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Journey Medical (DERM) grows Emrosi sales but flags going concern risk - Stock Titan
Journey Medical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - finance.yahoo.com
Journey Medical revenue rises 23% to $18.5 million in Q2 - Quiver Quantitative
Earnings To Watch: Journey Medical Corp (DERM) Q2 2026 -- GF Val - GuruFocus
Earnings To Watch: Journey Medical Corp (DERM) Q2 2026 -- GF Value Sees 6% Upside - Yahoo Finance
From the hardwood to healthcare: CEO Stephen Flatt’s journey to the top of long-term care - McKnight's Long-Term Care News
Journey Medical Corp expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Journey Medical Corp (DERM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 - Yahoo Finance
Journey Medical (DERM) Expected to Post Earnings on Tuesday - marketbeat.com
Vanguard Capital Management (DERM) discloses 774,556 Journey Medical shares in 13G/A - Stock Titan
Journey Medical Corp (DERM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Journey Medical Corp (DERM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DERM|Journey Medical Corp|Price:6.630|Chg%:+0.170 - TradingKey
Journey Medical Corp (DERM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Journey Medical Corp (DERM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Finanzdaten der Journey Medical Corp-Aktie (DERM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):